Home A-Z Index About Us Books Español
Sponsored Links

Sponsored Links

Diagnostic Criteria for Myasthenia Gravis

Neuromuscular transmission disorder characterized by fluctuating weakness and fatigability of bulbar and other voluntary muscles without loss of reflexes or impairment of sensation or other neurologic function.

Diagnostic criteria:

A. Characteristic signs and symptoms

One or more of the following:

  1. Diplopia, ptosis, dysarthria, weakness in chewing, difficulty in swallowing, muscle weakness with preserved deep tendon reflexes, and, less commonly, weakness of neck extension and flexion, and weakness of trunk muscles

  2. Increased weakness during exercise and repetitive use with at least partially restored strength after periods of rest

  3. Dramatic improvement in strength following administration of anticholinesterase drug (edrophonium (Tensilón®) and neostigmine);

and one or more of the following:

B. EMG and repetitive stimulation of a peripheral nerve: In myasthenia gravis repetitive stimulation at a rate of 2 per second shows characteristic decremental response which is reversed by edrophonium or neostigmine. Single fiber studies show increased jitter.

C. Antibodies to Acetylcholine Receptors


  • Congenital myasthenic syndrome, progressive restricted myopathies, steroid and inflammatory myopathies, motor neuron disease

  • Multiple sclerosis, variants of Guillain-Barré syndrome (e.g., Miller-Fisher syndrome)

  • Organophosphate toxicity, botulism, black widow spider venom

  • Eaton-Lambert syndrome

  • Stroke

  • Medications: neuromuscular blocking agents, aminoglycosides, penicillamine, antimalarial drugs, colistin, streptomycin, polymyxin B, tetracycline

  • Hypokalemia; hypophosphatemia

Severity: (Osserman classification):

I: Ocular myasthenia
IIA: Mild generalized myasthenia with slow progression: no crises, responsive to drugs
IIB. : Moderately severe generalized myasthenia : severe skeletal and bulbar involvement but no crises; drug response less than satisfactory
III: Acute fulminating myasthenia, rapid progression of severe symptoms, with respiratory crises and poor drug response
IV: Late severe myasthenia, same as III but progression over 2 years from class I to II


Related Criteria

McDonald Diagnostic Criteria for Multiple Sclerosis (MS)

NIH Diagnostic Criteria for Neurofibromatosis

Diagnostic Criteria for Tuberous Sclerosis Complex (TSC)

Diagnostic Criteria for Neurocysticercosis

Diagnostic Criteria and Associated Features of Restless Legs Syndrome (RLS)




  1. Ossermann KE. Myasthenia gravis. New York: Grune and Stratton; 1958.

  2. Engel AG. Myasthenic syndromes. In: Engel AG, Franzini Armstrong C, editors. Myology. 2nd ed. New York: McGraw Hill; 1994. p. 1798-835.

Sponsored Links


Created: October 11, 2006
Last Modified: 10/23/2010

MedicalCRITERIA.com © 2006 all rights reserved.                                                                     Contact Us.